Ventricular tachycardia in structurally normal hearts

被引:7
作者
Wall T.S. [1 ]
Freedman R.A. [1 ]
机构
[1] University of Utah Medical Center, Division of Cardiology, Salt Lake City, UT 84132
关键词
Ventricular Tachycardia; Catheter Ablation; Right Ventricular Outflow Tract; Brugada Syndrome; Right Bundle Branch Block;
D O I
10.1007/s11886-002-0038-0
中图分类号
学科分类号
摘要
This review focuses on four distinct syndromes of ventricular tachycardia that occur in the structurally normal heart. Recent advances in the fields of molecular biology and genetics, along with intracardiac mapping techniques, have led to a greater understanding of the underlying mechanisms of and therapeutic options for these syndromes. The cyclic AMP-mediated triggered activity tachycardias, including exercise-induced right ventricular outflow track tachycardia and repetitive monomorphic ventricular tachycardia, are the most common of these syndromes. Idiopathic left ventricular tachycardia, for which there is significant evidence for re-entry within the Purkinje network, is largely curable with catheter ablation. The long QT syndrome comprises a heterogeneous group of ion channel defects leading to prolongation of myocyte repolarization and Torsade de Pointes ventricular tachycardia. Brugada syndrome, a familial disorder of transmembrane ion transport, is felt to be the result of a group of sodium channel defects leading to characteristic electrocardiographic abnormalities, and syncope and sudden death. Primary focus is given to recent advances in our understanding of the underlying mechanism and current therapeutic approaches. © 2002 by Current Science Inc.
引用
收藏
页码:388 / 395
页数:7
相关论文
共 49 条
[41]  
Yasuda M., St segment elevation in the right precordial leads following administration of class ic antiarrhythmic drugs, Heart, 85, (2001)
[42]  
Autonomic and antiarrhythmic drug modulation of st segment elevation in patients with brugada syndrome, J Am Coll Cardiol, 27, pp. 1061-1070, (1996)
[43]  
Krishnan S.C., St segment elevation induced by class ic antiarrhythmic agents: Underlying electrophysiologic mechanisms and insights into drug-induced proarrhythmia, J Cardiovasc Electrophysiol, 9, pp. 1167-1172, (1998)
[44]  
Brugada P., Prognostic value of electrophysiologic investigations in brugada syndrome, J Cardiovasc Electrophysiol, 12, pp. 1004-1007, (2001)
[45]  
Chen Q., Genetic basis and molecular mechanism for idiopathic ventricular fibrillation, Nature, 392, pp. 293-294, (1998)
[46]  
Rook M.B., Human scn5a gene mutations alter cardiac sodium channel kinetics and are associated with the brugada syndrome, Cardiovasc Res, 44, pp. 507-517, (1999)
[47]  
Brugada P., Sudden death in patients and relatives with the syndrome of right bundle branch block, st segment elevation in the precordial leads v(1)to v(3)and sudden death, Eur Heart J, 21, pp. 321-326, (2000)
[48]  
Ikeda T., Assessment of noninvasive markers in identifying patients at risk in the brugada syndrome: Insight into risk stratification, J Am Coll Cardiol, 37, pp. 1628-1634, (2001)
[49]  
Takenaka S., Relatively benign clinical course in asymptomatic patients with brugada-type electrocardiogram without family history of sudden death, J Cardiovasc Electrophysiol, 12, pp. 2-6, (2001)